Erschienen in:
01.01.2006 | Research Letter
Rosiglitazone-associated pseudotumour cerebri
verfasst von:
S. Dagdelen, O. Gedik
Erschienen in:
Diabetologia
|
Ausgabe 1/2006
Einloggen, um Zugang zu erhalten
Excerpt
To the Editor: Several drugs may induce pseudotumour cerebri, which commonly presents with papilloedema, headache and/or transient visual disturbances. The diagnosis of pseudotumour cerebri should satisfy the following (Dandy’s modified) criteria: (1) signs and symptoms of elevated intracranial pressure; (2) a normal neurological examination except for an abducens palsy; (3) cause of elevated intracranial pressure not evident from neuroimaging; and (4) normal cerebrospinal fluid examinations except for an increased opening pressure [
1]. To the best of our knowledge, we report here the first case in the literature of a patient with rosiglitazone-associated pseudotumour cerebri. …